SPY328.79+2.27 0.70%
DIA266.72+2.37 0.90%
IXIC10,902.80+157.52 1.47%

Morgan Stanley Maintains Overweight on Axonics Modulation Tech, Raises Price Target to $42

Morgan Stanley maintains Axonics Modulation Tech (NASDAQ:AXNX) with a Overweight and raises the price target from $40 to $42.

Benzinga · -

Morgan Stanley maintains Axonics Modulation Tech (NASDAQ:AXNX) with a Overweight and raises the price target from $40 to $42.